Fundamental Data for WPI

WATSON PHA(NYSE:WPI)

Watson Pharmaceuticals, Inc. is a pharmaceutical company primarily engagedin the development, production, marketing and distribution of both branded and off-patent pharmaceutical products. The company''s branded pharmaceutical business operates primarily in three specialty areas: Dermatology, Women''s Health and General Products. The company''s products include therapeutic and preventive agents generally sold by prescription or over-the-counter for the treatment of human diseases and disorders.

# Employees: 5070

Address: 311 Bonnie Circle,Corona,CA,USA

Phone: 951 493-5300

Fax: 951 493-5836

Website: www.watsonpharm.com

Email: info@watson.com

Sector: Medical

Industry: MED-GENERIC DRG

Executive Officers

Paul M. Bisaro (Presi.; C.E.O.)

Mark W. Durand (Sr. V.P.; C.F.O.)

Allen Chao Ph.D. (Chmn.)

Thomas R. Giordano Ph.D. (Sr. V.P. Chief Info. Off.)

David A. Buchen (Sr. V.P.; Genl. Counsel; Sec.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/18/2010

Mean EPS (Next Qtr): $0.72

Mean EPS (Year): $2.59

Mean Estimate(Long Term): $11.27

P/E Ratio(Based on EPS estimate): 13.550

Number of Estimates: 15

Shares Performance

Period	WPI	Compare to S&P
YTD	32.29 %	9.49 %
4 Weeks	-1.84 %	-2.90 %
12 Weeks	-0.57 %	-6.26 %

Shares Information

Analyst Coverage: Y

Avg Volume: 1152305

Shares Outstanding: 105M

Market Cap: $3.72B

52 Week High: $37.95

52 Week Low: $20.76

P/E Ratio: 14.770

PEG Ratio: 1.200

Split: On 10/30/1997 WPI split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: 8.20 %

EPS Growth in Last Year: 40.43 %

Sales Growth in Last Quarter: -2.32 %

Sales Growth in Last Quarter: 3.34 %

Financials

Qtr Book Value: $1.61

Cash Flow/Share: $9.10

Change in Payout Ratio: 0.000

Price/Sales: 1.400